4.2 Article

Differences in Hemodynamic Parameters and Exercise Capacity Between Patients With Pulmonary Arterial Hypertension and Chronic Heart Failure

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/HCR.0b013e318272bc0b

Keywords

chronic heart failure; exercise; pulmonary arterial hypertension; rehabilitation

Ask authors/readers for more resources

INTRODUCTION: Although pulmonary arterial hypertension (PAH) and chronic heart failure (CHF) lead to exercise limitation, their pathophysiology is different. Our objective was to evaluate, using right heart catheterization and cardiopulmonary exercise testing, the difference in hemodynamic parameters and exercise capacity between PAH and CHF, which have the same subjective symptoms. METHODS: We studied 20 PAH (mean pulmonary artery pressure: 36 +/- 10 mmHg, all > 25 mmHg) and 20 CHF (ejection fraction: 35 +/- 10%, all < 40%) patients who underwent both cardiopulmonary exercise testing and right heart catheterization. All patients were in New York Heart Association functional class II or III. RESULTS: Peak oxygen uptake ((V) over dotO(2)) was lower for PAH patients than for CHF patients (11.7 +/- 3.2 mL.kg(-1).min(-1) vs 14.5 +/- 4.6 mL.kg(-1).min(-1), P = .03), while the slope of ventilation to carbon dioxide production ratio ((V) over dotE/(V) over dotCO(2)) was higher for PAH patients than for CHF patients (41.0 +/- 12.7 vs 28.0 +/- 9.0, P = .001), despite the similarity in their New York Heart Association functional class. Peak (V) over dotO(2) and (V) over dotE/(V) over dotCO(2) correlated with cardiac index for both groups. An important finding was that peak (V) over dotO(2) correlated with pulmonary vascular resistance for PAH patients (r = -0.46, P = .04) but not for CHF patients (r = 0.33, P = .15). Furthermore, peak (V) over dotO(2) correlated with pulmonary capillary wedge pressure for CHF patients (r = -0.47, P = .03) but not for PAH patients (r = 0.17, P = .47), while the (V) over dotE/(V) over dotCO(2) slope correlated with pulmonary capillary wedge pressure (r = 0.67, P = .002) but not with pulmonary vascular resistance (r = 0.12, P = .63) for CHF patients. CONCLUSION: Peak (V) over dotO(2) and (V) over dotE/(V) over dotCO(2) slope were worse for PAH patients than for CHF patients despite the similar subjective symptoms. This difference might be explained by an altered hemodynamic status.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Chondroitin sulfate mediates liver responses to injury induced by dual endothelin receptor inhibition

Gusty Rizky Teguh Ryanto, Kennosuke Yorifuji, Koji Ikeda, Noriaki Emoto

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

Predictive model of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension

Kennosuke Yorifuji, Yuko Uemura, Shinji Horibata, Goh Tsuji, Yoko Suzuki, Kazuhiko Nakayama, Takashi Hatae, Shunichi Kumagai, Noriaki Emoto

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Associations between functional tricuspid regurgitation and long-term outcomes for patients with pulmonary hypertension

Jun Mukai, Hidekazu Tanaka, Hiroyuki Sano, Shun Yokota, Makiko Suto, Hiroki Takada, Fumitaka Soga, Yutaka Hatani, Hiroki Matsuzoe, Keiko Hatazawa, Kensuke Matsumoto, Kazuhiko Nakayama, Noriaki Emoto, Ken-ichi Hirata

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2020)

Correction Multidisciplinary Sciences

Endothelial progeria induces adipose tissue senescence and impairs insulin sensitivity through senescence associated secretory phenotype (vol 11, 481, 2020)

Agian Jeffilano Barinda, Koji Ikeda, Dhite Bayu Nugroho, Donytra Arby Wardhana, Naoto Sasaki, Sakiko Honda, Ryota Urata, Satoaki Matoba, Ken-Ichi Hirata, Noriaki Emoto

NATURE COMMUNICATIONS (2020)

Editorial Material Pharmacology & Pharmacy

The Sixteenth International Conference on Endothelin (ET-16), Kobe, 2019 INTRODUCTION

Bambang Widyantoro, Gusty Rizky Teguh Ryanto, Noriaki Emoto

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2020)

Article Multidisciplinary Sciences

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension

Gusty R. T. Ryanto, Koji Ikeda, Kazuya Miyagawa, Ly Tu, Christophe Guignabert, Marc Humbert, Tomoyuki Fujiyama, Masashi Yanagisawa, Ken-ichi Hirata, Noriaki Emoto

Summary: The dysregulation of the activin A-bone morphogenetic protein receptor type 2 link in endothelium plays a critical role in the progression of pulmonary arterial hypertension. Inhibin-beta -A/activin-A in endothelial cells could be a potential pharmacotherapeutic target for the treatment of pulmonary arterial hypertension.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

GPNMB plays a protective role against obesity-related metabolic disorders by reducing macrophage inflammatory capacity

Adam Prabata, Koji Ikeda, Elda Putri Rahardini, Ken-Ichi Hirata, Noriaki Emoto

Summary: The study demonstrates that GPNMB negatively regulates macrophage inflammatory capacities and ameliorates WAT inflammation in obesity, making it a promising therapeutic target for metabolic disorders associated with obesity.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Review Biology

Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going

Andreas Haryono, Risa Ramadhiani, Gusty Rizky Teguh Ryanto, Noriaki Emoto

Summary: In this review, the basic functions of endothelin and related molecules, including their receptors and enzymes, are described. The important role of endothelin in cardiovascular diseases is discussed, along with the clinical evidence for targeting the endothelin pathway and the future scope of endothelin-targeting treatments. The current uses of endothelin receptor antagonists and advancements in treatment options are highlighted, providing an overview of endothelin research over the years and its potential future developments.

BIOLOGY-BASEL (2022)

Article Pharmacology & Pharmacy

The loss of endothelin-2 exhibits an anticancer effect in A549 human lung adenocarcinoma cell line

Ratih Paramita Suprapto, Yoko Suzuki, Tatsuya Nagano, Ken-Ichi Hirata, Noriaki Emoto

Summary: Lung adenocarcinoma, the leading cause of cancer-related deaths worldwide, was found to have increased expression of endothelin-2 (ET-2) which was associated with poor overall survival. Silencing ET-2 inhibited proliferation, migration, and invasion, and enhanced apoptosis in lung adenocarcinoma cells.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2022)

Article Biology

Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension

Keisuke Miwa, Yu Taniguchi, Hiroyuki Fujii, Yoichiro Matsuoka, Hiroyuki Onishi, Kenichi Yanaka, Yu Izawa, Yasunori Tsuboi, Atsushi Kono, Noriaki Emoto, Kenichi Hirata

Summary: Poor subpleural perfusion (PSP) on dual-energy computed tomography (DE-CT) is a specific imaging finding in chronic thromboembolic pulmonary hypertension (CTEPH) and suggests a different mechanism of microvasculopathy from that in pulmonary arterial hypertension (PAH).

LIFE-BASEL (2022)

Article Neurosciences

Gliovascular interface abnormality in mice with endothelial cell senescence

Shoji Kawauchi, Taiji Mizoguchi, Sayo Horibe, Toru Tanaka, Naoto Sasaki, Koji Ikeda, Noriaki Emoto, Ken-ichi Hirata, Yoshiyuki Rikitake

Summary: This study investigated the effects of aging-related changes on the neurovascular unit (NVU). It was found that senescence in the vascular endothelial cells led to morphological alterations in astrocytes and affected the localization of the water channel AQP4 at the gliovascular interface.
Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease

Hiroyuki Fujii, Yu Taniguchi, Sachiyo Yoneda, Keisuke Miwa, Yoichiro Matsuoka, Kenichi Yanaka, Yasunori Tsuboi, Noriaki Emoto, Kenichi Hirata

Summary: In this study, data from 149 patients with chronic thromboembolic pulmonary hypertension (CTEPH) were analyzed. The results showed that the efficacy and safety of balloon pulmonary angioplasty (BPA) for CTEPH with concurrent chronic obstructive pulmonary disease (COPD) were similar to those without COPD. Oxygenation and forced expiratory volume in 1 second/forced vital capacity showed improvement in patients with COPD. Therefore, BPA should be considered as a treatment option for CTEPH patients with concurrent COPD.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Review Biochemistry & Molecular Biology

Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension

Gusty Rizky Teguh Ryanto, Ahmad Musthafa, Tetsuya Hara, Noriaki Emoto

Summary: Advances in technology and biomedical knowledge have improved the diagnosis and treatment of rare diseases, including pulmonary arterial hypertension (PAH). This article explores the role of activins and inhibins in PAH development and their connection to signaling pathways implicated in the pathogenesis of PAH. It also discusses the potential therapeutic benefits of activin/inhibin-targeting drugs, such as sotatercep, in improving patient outcomes. Overall, this article highlights the importance of activin/inhibin signaling as a critical mediator in PAH development and its potential as a target for future treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Neurosciences

Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer's disease

Sayo Horibe, Takuo Emoto, Taiji Mizoguchi, Toru Tanaka, Shoji Kawauchi, Naoto Sasaki, Tomoya Yamashita, Koji Ikeda, Noriaki Emoto, Ken-ichi Hirata, Yoshiyuki Rikitake

Summary: Alzheimer's disease is a common neurodegenerative disease associated with aging. Endothelial cell senescence has been found in the brains of Alzheimer's disease patients, but its role in the pathogenesis of the disease is unclear. The study revealed that endothelial cell senescence alters microglial morphology and function, providing a potential clue for the prevention and treatment of Alzheimer's disease.
Article Cardiac & Cardiovascular Systems

Increased serum activin A level in congenital heart disease-associated pulmonary artery hypertension: A comparative study from the COHARD-PH registry

Muhammad R. Hadwiono, Anggoro B. Hartopo, Widya Wasityastuti, Dyah W. Anggrahini, Gusty R. T. Ryanto, Noriaki Emoto, Lucia K. Dinarti

Summary: This study found that Activin A may have a role in the development and progression of pulmonary artery hypertension (PAH) caused by uncorrected congenital heart disease (CHD-PAH). Serum levels of Activin A were significantly increased in subjects with uncorrected CHD, and were even more significantly elevated in CHD-PAH patients compared to controls. Therefore, the measurement of serum Activin A shows promise in identifying uncorrected CHD patients with PAH development and progression.

PULMONARY CIRCULATION (2023)

No Data Available